Issues of antithrombotic therapy in ACS patients with atrial fibrillation
| Autor: | A. M. Koryazina, G V Kovaleva, A T Volkova, N N Paykova, L Y Koroleva, V P Nosov, N A Kaydalova |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Acute coronary syndrome Rivaroxaban business.industry Warfarin Atrial fibrillation medicine.disease Dabigatran 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Internal medicine Antithrombotic medicine Cardiology cardiovascular diseases Cardiology and Cardiovascular Medicine business Stroke 030217 neurology & neurosurgery Fibrinolytic agent medicine.drug |
| Zdroj: | Kardiologiia. 17:22-30 |
| ISSN: | 0022-9040 |
| Popis: | The review analyzed current ideas on prevalence and clinical significance of atrial fibrillation following acute coronary syndrome; described modern approaches to administration of antithrombotic therapy; and addressed available clinical studies on the treatment with warfarin and new oral anticoagulants as a part of combination antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|